ADIPOQ and Miyoshi myopathy: Based on these interactions, potential therapeutic choices arise; the apolipoprotein peptide mimetic L-4F enhances adiponectin levels, reducing tumor burden, prolonging survival in MM and preventing MM bone disease [143].